Interim / Quarterly Report • Jun 30, 2012
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Half Year Report for the six months ended 30 June 2012
Primary Health Properties PLC ("PHP") is a UK Real Estate Investment Trust ("REIT").
The objective of the Group is to generate rental income and capital growth through investment in primary health property in the United Kingdom leased principally to GPs, NHS organisations and other associated healthcare users.
for more information visit www.phpgroup.co.uk
| Chairman's Statement | 2 |
|---|---|
| Managing Director's Review | 6 |
| Condensed Group Statement of | |
| Comprehensive Income | 17 |
| Condensed Group Balance Sheet | 18 |
| Condensed Group Cash Flow Statement | 20 |
| Condensed Group Statement of | |
| Changes in Equity | 22 |
| Notes to the Condensed | |
| Financial Statements | 24 |
| Independent review report to | |
| Primary Health Properties PLC | 31 |
| Directors' Responsibility Statement | 32 |
| Corporate Profile and Advisers | 33 |
| Six months ended 30 Jun 2012 |
Six months ended 30 Jun 2011 |
Year ended 31 Dec 2011 |
|
|---|---|---|---|
| Rental and related income | £16.2m | £15.3m | £30.7m |
| Operating profit before net valuation gain on property portfolio |
£13.4m | £12.6m | £25.1m |
| Total dividend paid to shareholders | 9.25p | 9.0p | 18.0p |
| Total investment property | £539.2m | £489.5m | £525.6m |
| Loan to value ratio | 56.4% | 55.6% | 57.8% |
| EPRA net asset value per share | 314.9p | 317.8p | 318.7p |
A number of successful transactions have been made by the Group on all fronts.
The acquisition of four investment properties was completed in the first half of the year for a total consideration of £11.5 million.
I am delighted to present the Group's half year report for the six months ended 30 June 2012.
The period under review has seen a number of successful transactions completed which enhance the Group's portfolio and ability to increase shareholder return. Further assets have been acquired and asset management projects undertaken which add to the contracted rent roll and income surplus that funds the continuing dividend payment.
Our core banking facilities have been renewed, a small equity issue completed and on 23 July 2012 PHP became the first UK REIT to issue a retail bond. All of this strengthens the capital and resource base of the Group and provides firepower to finance a strong pipeline of acquisition opportunities currently being documented or negotiated by our management team.
The long awaited Health and Social Care Act (the "Act") entered into statute on 27 March 2012 and further information emerged about the establishment of NHS Property Services Limited and the management of the NHS's Primary Care Estate. The Act brings major structural changes to the delivery of health care in England, transferring the commissioning of care to more localised Clinical Commissioning Groups. This supports a UK wide drive to deliver an increasing number of healthcare services within local communities. To do this efficiently and effectively, an increasing number of high quality primary care facilities will need to be provided. The Group is well placed to provide this investment and continues to deliver consistent market leading returns to its shareholders.
Rental income in the period increased by 6.3% to £16.21 million (30 June 2011: £15.25 million), due to acquisitions and rent reviews that were completed. The Group continues to achieve satisfactory growth on rent reviews, although the overall rate of increase has fallen slightly. Increases averaged 2.7% per annum on reviews completed in the six month period, down slightly from 3.0% achieved during 2011.
Costs were once again tightly controlled within the Group, aided by its external management model. Operating profit before finance costs, the revaluation of investment properties and derivatives increased by 6.5% to £13.4 million (30 June 2011: £12.6 million). Deducting debt costs, that include the increased margin since the refinance of the Group's core debt, adjusted earnings per share for the period were 6.1pence (30 June 2011: 8.3pence).
Four investment properties were acquired in the first half of the year for a total consideration of £11.5 million. The Group's investment property portfolio as at 30 June 2012 was independently valued at £545.2 million including commitments, providing a revaluation surplus of £0.63 million. Investment yields remained stable with an initial yield of 5.74% (31 December 2011: 5.74%).
On 19 July 2012, PHP contracted to buy a fully let investment in Luton for £3.9 million. Including this and a property held under a finance lease, the Group now holds 165 assets with a total value of £552.5 million.
Terms have been agreed for the purchase of a further £49.4 million of high quality medical centre assets and these acquisitions are currently being documented. In addition to this, a further significant pipeline of asset purchases is being negotiated, which we hope to secure in the second half of the year.
The Group completed the refinance of its main bi-lateral debt facilities on 2 April 2012 resulting in a new £175 million, four year interest only debt facility with the Group's main lenders Royal Bank of Scotland and Santander. There was no requirement to redeem the pre-existing interest rate swaps and incur any value eroding breakage fees. The Group now has a well-diversified group of lenders with a wide range of maturity dates.
The Company successfully completed a small share issue in May, issuing 6.2 million shares at 305 pence per share, a discount of 6.2% to the then share price, raising a net £18.4 million to provide equity for further acquisitions. The small dilution contributed to a slight reduction in
EPRA1 net asset value ("EPRA NAV") per share at 30 June 2012, standing at 314.9 pence, a fall of 1.2% from 318.7 pence as at 31 December 2011.
PHP recently announced the completion of a retail bond issue, the first issue of its kind by a UK REIT, raising £75 million from a new investor base. The bond was issued for a seven year term on an unsecured basis giving maximum flexibility to the Group as to how the funds are invested. These proceeds will be used alongside the banking facility headroom and new equity proceeds to fund further acquisitions through the coming months. The issue will pay a coupon of 5.375% per annum on a semi-annual basis.
The Company paid a second interim dividend of 9.25 pence per share in respect of 2011 to shareholders on 5 April 2012. The Board has approved the payment of a first interim dividend for 2012 of 9.25 pence per share, payable on 26 October 2012 to shareholders on the register on 28 September 2012. This will make a total of 18.5 pence per share paid in dividends to shareholders in 2012, the 16th successive year of dividend growth for the Company.
The Group has further strengthened its balance sheet in 2012. Its underlying property portfolio is producing benchmark beating returns and the Group has significant resources available to take advantage of opportunities to expand its portfolio through the remainder of 2012.
The Board is confident in the ability of the property portfolio and its management team to generate further growth from rent review and asset management projects. With the Act in place and work continuing to move the commissioning of primary care services into the hands of GPs, we are confident that the demand for new, modern facilities will increase and that we are ideally placed to satisfy this demand.
I look forward to another positive period for the remainder of 2012.
Graeme Elliot Chairman 21 August 2012
1 European Public Real Estate Association
The Group's asset portfolio has grown in the six months under review as further property acquisitions have been completed and a number of asset management projects from within the owned portfolio have been undertaken.
A modern, newly developed primary care centre completed and acquired in March 2012. The property is fully let to a 3 Partner GP Practice, the Local Health Board ("LHB") and a Pharmacy for 20 years, providing a purpose built, fit for purpose facility to replace the old terraced housing from which this practice previously operated.
| size: | 1,250 sqm |
|---|---|
| built: | March 2012 |
| cost: | £3.78m |
| patient numbers: | 9,500 |
| tenants: | GP practice, LHB and a pharmacy |
We have maintained a leading position within the primary care premises sector and established PHP as a leading participant in future developments
Royal Assent of the Health and Social Care Act 2012 introduces wide reaching structural changes to the delivery of healthcare services in England, the largest of the four UK NHS organisations. From April 2013, Primary Care Trusts ("PCTs") will be abolished and replaced by Clinical Commissioning Groups, whose management will mainly comprise of GPs. This will strengthen the drive to provide services within the local community and place further emphasis on primary care as the gateway to wider NHS facilities.
Although the commissioning of care is being transferred into GP management, there will be no change to the reimbursement of GP rent and property costs. This will be the responsibility of the newly formed National Commissioning Board which will carry the status of a Special Health Authority, so providing a continuing strong covenant to underpin the funding of the Group's rent roll. The precise structure of this body between national and regional operations is as yet unknown. During the period under review, the NHS Property Services Limited has also been formed to take on the ownership and management of the NHS's primary care estate when the PCTs are abolished.
We feel that all of the above combines to strengthen the need for the development of further purpose built modern primary care facilities from which a greater variety of healthcare services can be provided within the local community.
We have worked extremely hard in the first half of 2012 to ensure that the Group's leading position within the primary care premises sector is maintained and to position PHP to be a significant participant in future developments.
The Group's portfolio has grown in the six months under review as further property acquisitions have been completed and a number of asset management projects from within the owned portfolio have been undertaken.
Four acquisitions were completed in the period for a total of £11.5 million. As detailed below, these were spread across the United Kingdom, and were all high quality, modern premises with income contracted for terms longer than the Weighted Average Unexpired Lease Term ("WAULT") of the existing portfolio, helping to maintain the longevity of the Group's rental income.
A modern, purpose built health facility in Watton, Norfolk built in 2006 and acquired by PHP in 2012. The property houses a 6 Partner GP Practice and services a major part of the local health infrastructure.
| size: | 925 sqm |
|---|---|
| built: | July 2006 |
| cost: | £2.7m |
| patient | |
| numbers: | 12,750 |
| tenants: | GP practice, LGB |
| and pharmacy |
| Asset acquired | m2 | £m* | Occupational tenants |
|---|---|---|---|
| Conan Doyle Medical Centre, Edinburgh | 1,144 | 3.8 | 7 GP practice |
| Pharmacy Unit, Connahs Quay | 310 | 1.0 | Pharmacy at existing PHP site |
| Watton Medical Practice, Norfolk | 924 | 2.8 | 6 GP practice |
| Nantgarw Road Medical Centre, | 1,250 | 3.9 | 3 GP practice, Health Board and |
| Caerphilly, South Wales | pharmacy | ||
| 11.5 |
* including legal expenses
Asset management projects were completed at three sites in the period incurring capital expenditure of £0.5 million, but adding £0.03 million to rent roll with an average additional lease period secured of over 14 years.
The Group's portfolio produces continuing growth from rent reviews with a total of £0.21 million of rental income added to contracted rent roll from the completed review of £3.07 million of rent in the period. This gives an average annualised increase of 2.7% (2011: 3.0%).
At the start of the year, the Group had committed to forward fund the development of four further centres. One of these, a 795 square metre centre in Allesley, Coventry will be delivered and rent will commence in the coming weeks. The three other forward commitments are progressing as planned and are scheduled to be delivered on time.
The investment portfolio was independently valued as at 30 June 2012 at open market value by Lambert Smith Hampton Chartered Surveyors and Valuers at a total of £545.2 million. Including properties held under finance leases and some expansion land, the aggregate value of the Group's property assets at the balance sheet date was £548.6 million. Whilst commercial property values have generally fallen in 2012, the longevity of contracted income and strength of the underlying NHS covenant has led to investment yields for the Group's portfolio being stable across the period, reflecting an initial yield of 5.74% (31 December 2011: 5.74%).
| Number | 30 June | 31 December | |
|---|---|---|---|
| of | 2012 | 2011 | |
| properties | £m | £m | |
| Investment properties | 159 | 533.7 | 521.2 |
| Properties in the course of development | 4 | 5.5 | 4.4 |
| Total properties | 163 | 539.2 | 525.6 |
| Finance leases and expansion land | 1 | 3.1 | 3.1 |
| Total owned and leased | 164 | 542.3 | 528.7 |
| Balance of purchases committed at the period end | - | 6.3 | 11.0 |
| Total owned, leased and committed at the balance sheet date | 164 | 548.6 | 539.7 |
| Purchases committed after the period end | 1 | 3.9 | |
| Total owned, leased and committed | 165 | 552.5 |
The Group has continued to acquire assets since the balance sheet date with a standing let investment in Luton being acquired for £3.9 million on 19 July 2012.
| Asset committed | m2 | Occupational tenants |
|---|---|---|
| Kingsway Health Centre, Luton | 1,281 | Wholly let to PCT |
Following this recent activity, the Group's portfolio numbers 165 assets with a total value of some £552.5 million. Annualised rent roll stands at £33.2 million including commitments and the WAULT of the portfolio stands at 16.0 years (31 December 2011: 16.3 years).
Valuing the portfolio held at 30 June 2012 using a discounted cash flow ("DCF") methodology, to reflect the long term stable cash flow from the occupational leases, produces a value of £595.1 million. Compared to the LSH valuation of £548.6 million, the difference in value represents 63 pence per share in net asset value terms.
In the DCF valuation, cash flows from the assets are discounted at 7%. This is based on a margin of 250 basis points over an historic long term gilt yield of 4.5%. At current gilt yields, this would actually be a margin of approximately 470 basis points over the 16 year gilt.
In my 2011 year-end report, I set out how the Group benchmarks its real estate performance against the IPD Healthcare Property Index. This index was published in May 2012 and confirmed that the Group's assets had outperformed the Index in 2011. PHP's portfolio delivered a total return in 2011 of 10.1% against the primary care property element of the Index of 9.4%.
For the 12 month period to 30 June 2012, the Group's property portfolio has shown an annualised total return of 7.19%, compared to the IPD All Property Index for the same period that showed 4.4%.
PHP has a strong pipeline of potential investment purchases and opportunities to forward fund the development of new centres. At the time of writing this review, we have agreed terms to
| Analysis of rental income by geographic region | |||
|---|---|---|---|
| ------------------------------------------------ | -- | -- | -- |
| Scotland | 8% | |
|---|---|---|
| North | 4% | |
| Yorkshire & Humberside | 8% | |
| North West | 10% | |
| East Midlands | 12% | |
| West Midlands East Anglia Wales |
12% 2% 10% |
|
| South East | 27% | |
| London | 4% | |
| South West | 3% | |
| HM Govt 1% Pharmacy 9% NHS 15% Other 1% GPs 74% |
Covenant analysis by annual rent 90% of the Group's rent roll is paid directly or indirectly by the Government. |
|
| Rowlands 7% | Analysis of pharmacy rental income | |
| Boots 8% Co-op 5% Large Independent (6 units or more) 13% Small Independent (5 units or less) 24% Lloyds 43% |
Pharmacy rents represent 9% of total income. 63% of this is derived from national covenants. |
|
| More than 20 years 10% Less than 5 years 2% 5-15 years 36% 15-20 years 52% |
Analysis of annualised rent by unexpired lease term 62% of occupational leases have a remaining life of 15 years or longer. The weighted average lease length |
|
| (including commitments) is 16 years. |
acquire over £49.4 million of standing let investments and forward funded developments and these transactions are currently being documented. A further sizeable tranche of acquisitions is also being negotiated with all transactions continuing to apply the Group's prudent acquisition policies that target assets that contribute immediately to profitability but also have potential for future growth.
| Six months to 30 June 2012 £m |
Six months to 30 June 2011 £m |
Year to 31 Dec 2011 £m |
|
|---|---|---|---|
| Rental and related income | 16.2 | 15.2 | 30.7 |
| Expenses | (2.8) | (2.6) | (5.6) |
| Operating profit before revaluation gain and financing | 13.4 | 12.6 | 25.1 |
| Net financing costs | (9.0) | (7.2) | (15.4) |
| Profit on sale of AHMP shares | - | 0.3 | 0.3 |
| Underlying profit before revaluation gain, fair value movement on interest rate swaps and profit on |
|||
| sale of investment | 4.4 | 5.7 | 10.0 |
| Fair value (loss)/gain on interest rate swaps | (0.8) | 1.0 | (8.0) |
| Revaluation gain on property portfolio | 0.6 | 5.2 | 10.6 |
| Profit before tax | 4.2 | 11.9 | 12.6 |
The asset purchases, property enhancements and rent review uplifts detailed above have combined to increase rents received in the period to £16.2 million, an increase of 6.6% over the same period last year.
Fees paid to the joint managers were stable at 0.77% of gross assets (2011: 0.77%), but the proportion will reduce through the remainder of the year as the sliding scale fee rate, introduced in 2011, has an impact as gross assets increase further above £500 million. Profits before financing and revaluations increased by 6.4% to £13.4 million (six months to 30 June 2011: £12.6 million).
Net finance costs increased for the six month period, as acquisitions and the increased cost of the Group's bank finance impacted results. The impact will be less in future periods due to income from upcoming rent reviews and further property acquisitions.
Earnings per share, excluding property revaluation and the change in the Mark to Model of the Group's interest rate derivatives, were 6.1 pence (six months to 30 June 2011: 8.3 pence).
A purpose built primary care centre located in Pelton, County Durham, to be completed Q3 2012. The property will provide 1,613m2 of primary care space to include a pharmacy and is built alongside a new public library serving the local community.
| size: | 1,613 sqm |
|---|---|
| expected completion: Q3 2012 | |
| cost: | £4.15m |
| patient numbers: | 8,500 |
| tenants: | GP practice, PCT and a pharmacy |
The dividend announced with this statement brings cash dividends to date in 2012 to a total of 18.5 pence per share, an increase of 2.8% over that paid in 2011. This will be the 16th consecutive year of dividend growth. Once again, no portion of this dividend represents a Property Income Distribution ("PID").
In May 2012, the Company undertook a small capital raising, issuing a total of 6,229,509 shares at a price of 305 pence per share, a small discount to the then share price and a discount of 4.3% to the 31 December 2011 EPRA NAV. The net proceeds of the issue of £18.4 million have been used to fund property acquisitions and amounts paid towards commitments in the period and since the balance sheet date. A further 107,332 shares have been issued in the period to satisfy the scrip alternative to the cash dividend paid in April.
EPRA NAV excludes fair value adjustments of debt and associated derivatives. As a result of the activities detailed above, EPRA NAV per share has fallen by 1.2% in the period to 314.9 pence (31 December 2011: 318.7 pence).
The management team has worked diligently to secure the Group's underlying banking facilities and to expand the range of providers of debt and facility maturities to spread any refinance risk. The largest part of this exercise was completed on 2 April 2012, when the Group completed the refinance of its core £175 million bi-lateral loans into a new four year, interest only, "Club" facility provided by Royal Bank of Scotland plc and Santander Banking Group.
The Allied Irish Banks plc ("AIB") facility was reduced to £27 million and will run to its planned maturity in January 2013.
Total facilities available to the Group as at 30 June 2012 were £384 million, for an average term of 5.2 years. As at the balance sheet date, £301 million was drawn, leaving headroom for additional asset purchases and the refinance of the AIB debt. Group LTV stood at 56.4% (31 December 2011: 57.8%). The average margin on the Group's floating rate debt reflecting the refinance detailed above stands at 230 basis points (31 December 2011: 80 basis points).
On 23 July 2012, the Company issued a £75 million, seven year retail bond with an annual coupon of 5.375%, payable semi-annually. The bond is unrated and was issued on an unsecured basis, giving total flexibility over the use of the proceeds. These funds will be used to satisfy asset acquisitions and be invested at the earliest opportunity. Pending this, the funds have been used to pay down the revolving elements of the banking facilities which are available to be re-drawn as and when needed.
The Group's underlying long term, strong covenanted income streams and well managed portfolio, demonstrating consistent returns and growth potential, combined to present a compelling investment case for fixed income investors such that the offer period for the issue had to be closed a week earlier than planned as PHP quickly reached its target maximum issue size of £75 million. The bond issue, a first for a UK REIT, provides additional resource for investment to grow the portfollio and increase shareholder returns.
Another achievement of the debt refinance outlined above was that it was secured without the requirement to break any of the Group's interest rate swap agreements. This avoided crystallising large breakage costs associated with cancelling interest rate derivatives and the capital value erosion that would entail. The Mark to Model liability of the Group's derivative portfolio stood at £49.3 million at the balance sheet date (31 December 2011 - £49.5 million).
Set out above and in the financial statements are details of the Group's business activities, and development, performance and position including its cash flows, liquidity position and borrowing facilities. The Directors believe that the Group is well placed to manage its business risks successfully, despite the continuing uncertain general economic outlook. Having reviewed the Group's current position and cash flow projections, actual and prospective debt facilities and covenant cover, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. The Directors continue to adopt the going concern basis of accounting in preparing the financial statements.
The Group's business is underpinned by long term occupational leases in a sector where demand is consistent and no over supply exists. 90% of the rent roll is directly or indirectly received from the NHS with leases having an average remaining term of 16 years. 93% of today's income contracted will still be received in 10 years' time.
I am confident that we will see numerous opportunities to increase assets under management as new modern premises are demanded to provide the infrastructure from which modern day primary care services are delivered. The changes to the management and commissioning of care in England are now being implemented, removing considerable uncertainty from the market and showing signs of a return to a more normal volume of new centre approvals.
The outlook for the Group is positive as the funds that have been secured are invested in assets that will enhance returns to shareholders.
Harry Hyman Managing Director 21 August 2012
| Allesley | |
|---|---|
| size: | 1,243 sqm |
| expected completion: Q3 2012 | |
| cost: | £2.81m |
| patient numbers: | 14,850 |
| tenants: | GP practice and a pharmacy |
| size: | 773 sqm |
|---|---|
| expected completion: Q1 2013 | |
| cost: | £2.43m |
| patient numbers: | 6,400 |
| tenants: | GP practice and a pharmacy |
A modern purpose built health centre in Luton, Bedfordshire, constructed in 2008. The centre is fully let to Luton Primary Care Trust with nearly 17 years remaining on the lease.
| size: | 1,281 sqm |
|---|---|
| built: | February 2008 |
| cost: | £3.9m |
| patient numbers: | 7,700 |
| tenants: | PCT |
The 2011 Annual Report includes details of the Group's principal financial risks which may be summarised as follows:
Further details of how the Audit Committee monitors risks and how these are mitigated can be found in the Group's 2011 Annual Report.
for the six months ended 30 June 2012
| Notes | Six months ended 30 June 2012 £000 (unaudited) |
Six months ended 30 June 2011 £000 (unaudited) |
Year ended 31 Dec 2011 £000 (audited) |
|
|---|---|---|---|---|
| Rental income Finance lease income |
16,038 172 |
15,079 171 |
30,333 343 |
|
| Rental and related income Direct property expenses Administrative expenses |
9 | 16,210 (175) (2,592) |
15,250 (182) (2,450) |
30,676 (436) (5,123) |
| Operating profit before net valuation gain on property portfolio Profit on sale of available for sale ("AFS") investment Net valuation gain on property portfolio |
3 | 13,443 - 631 |
12,618 312 5,219 |
25,117 312 10,584 |
| Operating profit before financing costs Finance income Finance costs Fair value (loss)/gain on derivative interest rate swaps and amortisation of cash flow hedging reserve |
5 6 6 |
14,074 175 (9,308) (785) |
18,149 212 (7,451) 1,041 |
36,013 414 (15,831) (7,947) |
| Profit on ordinary activities before tax Current taxation credit |
7 | 4,156 - |
11,951 2 |
12,649 5 |
| Profit for the period 1 Fair value movement on interest rate swaps treated as cash flow hedges Recycling of previously unrealised gain on current asset investment |
4,156 982 - |
11,953 1,165 (73) |
12,654 (13,613) (73) |
|
| Other comprehensive income/(loss) | 982 | 1,092 | (13,686) | |
| Total comprehensive income/(loss) for the period net of tax |
5,138 | 13,045 | (1,032) | |
| Earnings per share • basic and diluted 2 Adjusted earnings per share3 |
4 | 5.9p | 18.3p | 19.0p |
| • basic and diluted2 | 4 | 6.1p | 8.3p | 14.5p |
The above relates wholly to continuing operations.
1 Wholly attributable to equity shareholders of Primary Health Properties PLC.
2 There is no difference between basic and fully diluted EPS.
3 Adjusted for large one off items and movements in fair value of properties and derivatives. See note 4.
at 30 June 2012
| At | At | At | |
|---|---|---|---|
| 30 June | 30 June | 31 Dec | |
| 2012 | 2011 | 2011 | |
| £000 | £000 | £000 | |
| restated3 | |||
| Notes | (unaudited) | (unaudited) | (audited) |
| Non current assets | |||
| Investment properties 2,3 |
539,154 | 489,516 | 525,586 |
| Net investment in finance leases | 3,084 | 3,052 | 3,069 |
| Derivative interest rate swaps | 8 | 1,196 | 24 |
| 542,246 | 493,764 | 528,679 | |
| Current assets | |||
| Trade and other receivables | 3,116 | 3,045 | 2,633 |
| Net investment in finance leases | 25 | 39 | 30 |
| Cash and cash equivalents | 964 | 915 | 77 |
| 4,105 | 3,999 | 2,740 | |
| Total assets | 546,351 | 497,763 | 531,419 |
| Current liabilities | |||
| Term loans 10 |
(27,610) | (574) | (592) |
| Derivative interest rate swaps | (7,126) | (15,818) | (23,866) |
| Trade and other payables | (6,975) | (4,875) | (5,831) |
| Deferred rental income | (6,848) | (6,144) | (6,624) |
| (48,559) | (27,411) | (36,913) | |
| Non current liabilities | |||
| Term loans 10 |
(269,956) | (268,300) | (300,747) |
| Derivative interest rate swaps | (42,148) | (14,019) | (25,639) |
| (312,104) | (282,319) | (326,386) | |
| Total liabilities | (360,663) | (309,730) | (363,299) |
| Net assets | 185,688 | 188,033 | 168,120 |
| At 30 June 2012 £000 |
At 30 June 2011 £000 |
At 31 Dec 2011 £000 |
||
|---|---|---|---|---|
| Notes | (unaudited) | (unaudited) | (audited) | |
| Equity | ||||
| Share capital | 37,305 | 34,088 | 34,136 | |
| Share premium account | 54,722 | 54,178 | 54,430 | |
| Capital reserve | 1,618 | 1,618 | 1,618 | |
| Special reserve | 72,689 | 57,405 | 57,405 | |
| Cash flow hedging reserve | (25,910) | (12,114) | (26,892) | |
| Retained earnings | 45,264 | 52,858 | 47,423 | |
| Total equity 1 | 185,688 | 188,033 | 168,120 | |
| Net asset value per share | ||||
| • Basic | 11 | 248.9p | 275.8p | 246.3p |
| • EPRA2 net asset value per share | 11 | 314.9p | 317.8p | 318.7p |
1 Wholly attributable to equity shareholders of Primary Health Properties PLC.
2 See definition of 'EPRA' on page 4.
3 Principal repayments on Aviva fixed term loan of £0.6 million restated to current liabilities from non-current liabilities. This reclassification has no effect on net assets.
for the six months ended 30 June 2012
| Six | Six | ||
|---|---|---|---|
| months | months | Year | |
| ended | ended | ended | |
| 30 June | 30 June | 31 Dec | |
| 2012 | 2011 | 2011 | |
| £000 | £000 | £000 | |
| (unaudited) | (unaudited) | (audited) | |
| Operating activities | |||
| Profit before tax | 4,156 | 11,951 | 12,649 |
| Less: Finance income | (175) | (212) | (414) |
| Plus: Finance costs | 9,308 | 7,451 | 15,831 |
| Plus: Fair value loss/(gain) on derivatives and | |||
| amortisation of cash flow hedging reserve | 785 | (1,041) | 7,947 |
| Operating profit before financing | 14,074 | 18,149 | 36,013 |
| Adjustments to reconcile Group operating profit | |||
| to net cash flows from operating activities: | |||
| Revaluation gain on property portfolio | (631) | (5,219) | (10,584) |
| Profit on sale of AFS investment | - | (312) | (312) |
| Increase in trade and other receivables | (488) | (504) | (146) |
| Increase in trade and other payables | 634 | 41 | 1,095 |
| Cash generated from operations | 13,589 | 12,155 | 26,066 |
| UK REIT conversion charge instalment | - | (1,998) | (1,998) |
| Taxation paid | - | (48) | (43) |
| Net cash flow from operating activities | 13,589 | 10,109 | 24,025 |
| Investing activities | |||
| Payments for investment properties | (12,937) | (15,007) | (45,712) |
| Receipt from sale of shares in AFS investment | - | 788 | 788 |
| Interest received on commitments | - | 58 | 296 |
| Bank interest received | 56 | 25 | 35 |
| Other interest received | - | - | 4 |
| Net cash flow used in investing activities | (12,881) | (14,136) | (44,589) |
| Six months ended 30 June 2012 £000 (unaudited) |
Six months ended 30 June 2011 £000 (unaudited) |
Year ended 31 Dec 2011 £000 (audited) |
|
|---|---|---|---|
| Financing activities | |||
| Proceeds from issue of shares (net of expenses) | 18,399 | 15,605 | 15,605 |
| Term bank loan drawdowns | 36,335 | 18,250 | 145,953 |
| Term bank loan repayments | (19,792) | (3,274) | (111,007) |
| Temporary offset of proceeds of share issue | |||
| against revolving bank loan | (18,399) | (13,450) | - |
| Swap interest payable | (3,238) | (4,457) | (8,833) |
| Non utilisation fees | (176) | - | (224) |
| Loan arrangement fees paid | (2,280) | (54) | (1,690) |
| Interest paid | (4,701) | (2,685) | (5,454) |
| Swap buy back costs | - | - | (2,880) |
| Equity dividends paid (net of scrip dividend) | (5,969) | (5,363) | (11,199) |
| Net cash flow from financing activities | 179 | 4,572 | 20,271 |
| Movement in cash and cash equivalents | |||
| for the period | 887 | 545 | (293) |
| Cash and cash equivalents at start of period | 77 | 370 | 370 |
| Cash and cash e quivalents at end of period | 964 | 915 | 77 |
| Share | Share | Capital | Special | Cash flow hedging |
Retained | ||
|---|---|---|---|---|---|---|---|
| capital | premium | reserve | reserve1 | reserve | earnings | Total | |
| £000 | £000 | £000 | £000 | £000 | £000 | £000 | |
| Six months ended 30 June 2012 (unaudited) | |||||||
| 1 January 2012 | 34,136 | 54,430 | 1,618 | 57,405 | (26,892) | 47,423 | 168,120 |
| Profit for the period | - | - | - | - | - | 4,156 | 4,156 |
| Income and expense recognised | |||||||
| directly in equity: | |||||||
| Fair value movement on interest | |||||||
| rate swaps and amortisation of | |||||||
| cash flow hedging reserve | - | - | - | - | 982 | - | 982 |
| Total comprehensive income | - | - | - | - | 982 | 4,156 | 5,138 |
| Proceeds from capital raisings | 3,115 | - | - | 15,885 | - | - | 19,000 |
| Expenses of capital raisings | - | - | - | (601) | - | - | (601) |
| Dividends paid: | |||||||
| Second interim dividend for period | |||||||
| ended 31.12.11 (9.25p) | - | - | - | - | - | (5,969) | (5,969) |
| Scrip dividends in lieu of interim | |||||||
| cash dividends | 54 | 292 | - | - | - | (346) | - |
| 30 June 2012 | 37,305 | 54,722 | 1,618 | 72,689 | (25,910) | 45,264 | 185,688 |
| Six months ended 30 June 2011 (unaudited) | |||||||
| 1 January 2011 | 31,401 | 53,934 | 1,618 | 44,442 | (13,279) | 46,630 | 164,746 |
| Profit for the period | - | - | - | - | - | 11,953 | 11,953 |
| Income and expense recognised directly in equity: |
|||||||
| Fair value movement on interest rate | |||||||
| swaps treated as cash flow hedges | - | - | - | - | 1,165 | - | 1,165 |
| Recycling of previously unrealised gain | - | - | - | - | - | (73) | (73) |
| Total comprehensive income | - | - | - | - | 1,165 | 11,880 | 13,045 |
| Proceeds from capital raisings | 2,642 | - | - | 13,474 | - | - | 16,116 |
| Expenses of capital raisings | - | - | - | (511) | - | - | (511) |
| Dividends paid: | |||||||
| Second interim dividend for period | |||||||
| ended 31.12.10 (9.00p) | - | - | - | - | - | (5,363) | (5,363) |
| Scrip dividends in lieu of interim | |||||||
| cash dividends | 45 | 244 | - | - | - | (289) | - |
| Share capital £000 |
Share premium £000 |
Capital reserve £000 |
Special reserve1 £000 |
Cash flow hedging reserve £000 |
Retained earnings £000 |
Total £000 |
|
|---|---|---|---|---|---|---|---|
| Year ended 31 December 2011 (audited) | |||||||
| 1 January 2011 | 31,401 | 53,934 | 1,618 | 44,442 | (13,279) | 46,630 | 164,746 |
| Profit for the year | - | - | - | - | - | 12,654 | 12,654 |
| Income and expense recognised | |||||||
| directly in equity: | |||||||
| Fair value movement on interest | |||||||
| rate swaps and amortisation of | |||||||
| cash flow hedging reserve | - | - | - | - | (13,613) | - | (13,613) |
| Recycling of previously unrealised gain | - | - | - | - | - | (73) | (73) |
| Total comprehensive income | - | - | - | - | (13,613) | 12,581 | (1,032) |
| Proceeds from capital raisings | 2,642 | - | - | 13,474 | - | - | 16,116 |
| Expenses of capital raisings | - | - | - | (511) | - | - | (511) |
| Dividends paid: | |||||||
| Second interim dividend for the year | |||||||
| ended 31 December 2010 (9.00p) | - | - | - | - | - | (5,363) | (5,363) |
| Scrip dividends in lieu of second | |||||||
| interim cash dividend (net of expenses) | 45 | 244 | - | - | - | (289) | - |
| First interim dividend for the year | |||||||
| ended 31 December 2011 (9.00p) | - | - | - | - | - | (5,836) | (5,836) |
| Scrip dividends in lieu of interim | |||||||
| cash dividends (net of expenses) | 48 | 252 | - | - | - | (300) | - |
| 31 December 2011 | 34,136 | 54,430 | 1,618 | 57,405 | (26,892) | 47,423 | 168,120 |
1 The Special Reserve is a distributable reserve
The financial information set out in this report does not constitute statutory accounts as defined in Section 434 of the Companies Act 2006. The Group's statutory financial statements for the year ended 31 December 2011 have been filed with the Registrar of Companies. The auditors' report on these financial statements was unqualified and did not contain a statement under section 498(2) or 498(3) of the Companies Act 2006.
The condensed consolidated interim financial statements of the Group are unaudited but have been formally reviewed by the auditors and their report to the Company is included on page 31.
These condensed interim financial statements of the Group for the six months ended 30 June 2012 were approved and authorised for issue by the Board of Directors on 21 August 2012.
The half year report for the six months ended 30 June 2012 has been prepared in accordance with IAS 34 'Interim Financial Reporting' and reflects consistent accounting policies as set out in the Group's financial statements at 31 December 2011 which have been prepared in accordance with IFRS as adopted by the European Union.
The half year report does not include all the information and disclosures required in the statutory financial statements and should be read in conjunction with the Group's financial statements as at 31 December 2011.
The financial statements are presented in Sterling rounded to the nearest thousand.
The Directors are of the opinion that the Group has one operating and reportable segment, being investment in property in the United Kingdom leased principally to GPs, NHS organisations and other associated health care users.
The Group's property portfolio is let to tenants with strong covenants and the acquisition pipeline is strong. In the period the Group has finalised the refinancing of £175 million of bank debt facilities into a new four year interest only facility. This has extended the average maturity of the Group's banking facilities to over five years. The loan to value ratio is currently 56.4%, well below the maximum Group banking covenant of 70%. The Group has announced the issue of a £75 million, seven year unsecured retail bond with an interest rate of 5.375%. For these reasons the Directors' continue to adopt the going concern basis of accounting in preparing the financial statements.
Investment properties have been independently valued at fair value by Lambert Smith Hampton, Chartered Surveyors and Valuers, as at 30 June 2012 in accordance with IAS 40: Investment Property.
The revaluation gain for the six months ended 30 June 2012 amounted to £0.6 million. The revaluation gain for the year ended 31 December 2011 amounted to £10.6 million and the gain for the six months ended 30 June 2011 amounted to £5.2 million.
Property additions, including acquisitions, for the six months ended 30 June 2012 amounted to £12.9 million. No properties were disposed of in the six months to 30 June 2012. Commitments outstanding at 30 June 2012 amounted to £6.3 million (31 December 2011: £11.0 million).
Property additions for the 12 months ended 31 December 2011 and the six months ended 30 June 2011 amounted to £45.7 million and £15.0 million respectively. There were no property disposals during these periods.
| As at 30 June 2012 | 444,356 | 89,330 | 5,468 | 539,154 |
|---|---|---|---|---|
| Revaluation gain for the period | 210 | 386 | 35 | 631 |
| Additions | 373 | 21 | 1,058 | 1,452 |
| Acquisitions | 10,528 | 957 | - | 11,485 |
| As at 1 January 2012 | 433,245 | 87,966 | 4,375 | 525,586 |
| (unaudited) | (unaudited) | (unaudited) | (unaudited) | |
| £000 | £000 | £000 | £000 | |
| freehold | leasehold | construction | Total | |
| properties | long | under | ||
| Investment | properties | properties | ||
| Investment | Investment |
The purpose of calculating an adjusted earnings per share is to provide a better indication of dividend cover for the period by excluding large one-off items affecting earnings per share during the period.
| Six months ended | Six months ended | Year ended | |
|---|---|---|---|
| 30 June 2012 | 30 June 2011 | 31 Dec 2011 | |
| £000 | £000 | £000 | |
| (unaudited) | (unaudited) | (audited) | |
| Net profit attributable to Ordinary Shareholders | |||
| Basic profit | 4,156 | 11,953 | 12,654 |
| Adjusted profit - Adjustments to remove: | |||
| Net gain on revaluation of property | (631) | (5,219) | (10,584) |
| Fair value loss/(gain) on derivatives 1 | 785 | (1,041) | 7,947 |
| Profit on sales of AFS investment | - | (312) | (312) |
| Taxation | - | (2) | (5) |
| Adjusted basic and diluted earnings 2 | 4,310 | 5,379 | 9,700 |
| Number of Ordinary Shares 3 | 70,413,807 | 65,157,643 | 66,696,096 |
| Earnings per share 2 | 5.9p | 18.3p | 19.0p |
| Earnings per share - Adjusted 1 | 6.1p | 8.3p | 14.5p |
1 In view of the continuing volatility in the mark to model adjustment in respect of the period end valuation of derivatives that flows through the Condensed Group Statement of Comprehensive Income, the Directors believe that it is appropriate to remove the loss/(gain) in the calculation of adjusted earnings.
2 There is no difference between basic and fully diluted EPS.
3 Weighted average number of Ordinary Shares in issue during the period. In April 2012, the Group issued 0.1 million Ordinary Shares following the scrip dividend issue and in May 2012, 6.2 million Ordinary Shares were issued by way of a Placing.
| Six months ended 30 June 2012 £000 (unaudited) |
Six months ended 30 June 2011 £000 (unaudited) |
Year ended 31 Dec 2011 £000 (audited) |
|
|---|---|---|---|
| Interest income on financial assets | |||
| not at fair value through profit or loss | |||
| Bank interest | 57 | 33 | 70 |
| Development loan interest | 65 | 177 | 249 |
| Other interest | 53 | 2 | 95 |
| 175 | 212 | 414 |
| Six months | Six months | Year | |
|---|---|---|---|
| ended | ended | ended | |
| 30 June | 30 June | 31 Dec | |
| 2012 | 2011 | 2011 | |
| £000 | £000 | £000 | |
| (unaudited) | (unaudited) | (audited) | |
| Interest expense on financial liabilities | |||
| (i) Interest paid | |||
| Bank loan interest paid | 5,433 | 2,690 | 5,792 |
| Bank swap interest paid | 3,219 | 4,438 | 8,768 |
| Other interest paid | 10 | 13 | - |
| Notional UK-REIT interest | - | 5 | 5 |
| Bank facility non utilisation fees | 206 | 60 | 288 |
| Bank charges and loan commitment fees | 440 | 245 | 978 |
| 9,308 | 7,451 | 15,831 | |
| (ii) Derivatives | |||
| Net fair value loss/(gain) on interest rate swaps | 113 | (1,041) | 7,891 |
| Amortisation of cash flow hedging reserve | 672 | - | 56 |
| 785 | (1,041) | 7,947 |
The fair value loss on derivatives recognised in the Condensed Group Statement of Comprehensive Income has arisen from the interest rate swaps for which hedge accounting does not apply. A fair value gain on derivatives which meets the hedge effectiveness criteria under IAS39 of £0.3 million (30 June 2011: gain of £1.2 million) is accounted for directly in equity, together with amortisation of the hedging reserve of £0.7 million (30 June 2011: £ nil).
Net finance costs excluding fair value movements on derivatives can be summarised as follows:
| Net finance costs | 9,133 | 7,239 | 15,417 |
|---|---|---|---|
| £000 | £000 | £000 | |
| (unaudited) | (unaudited) | (audited) | |
| 30 June | 30 June | 31 Dec | |
| 2012 | 2011 | 2011 | |
| Six months | Six months | Year | |
| ended | ended | ended |
| Six months | Six months | Year |
|---|---|---|
| ended | ended | ended |
| 30 June | 30 June | 31 Dec |
| 2012 | 2011 | 2011 |
| £000 | £000 | £000 |
| (unaudited) | (unaudited) | (audited) |
| UK Corporation tax credit on non property income - |
(2) | (5) |
| - | (2) | (5) |
| Six | Six | ||
|---|---|---|---|
| months | months | Year | |
| ended | ended | ended | |
| 30 June | 30 June | 31 Dec | |
| 2012 | 2011 | 2011 | |
| £000 (unaudited) |
£000 (unaudited) |
£000 (audited) |
|
| Second interim dividend for the period ended 31 December 2011 (9.25p) |
|||
| paid 2 April 2012 (2011: 9.00p) | 5,969 | 5,363 | 5,363 |
| Scrip dividend in lieu of second interim | |||
| cash dividend | 346 | 289 | 289 |
| First interim dividend for the period ended 31 December 2011: (9.00p) |
|||
| paid 28 October 2011 | - | - | 5,836 |
| Scrip dividend in lieu of first interim | |||
| cash dividend | - | - | 300 |
| 6,315 | 5,652 | 11,788 | |
| Per share | 9.25p | 9.00p | 18.00p |
The Board proposes to pay an interim cash dividend of 9.25p per Ordinary Share for the six months to 30 June 2012, payable on 26 October 2012. This dividend will not be a Property Income Distribution ("PID").
As the portfolio has grown, administrative expenses as a proportion of rental and related income fell to 16.0% (30 June 2011: 16.1%). This equates to an annualised rate of 1.0% of gross real estate assets (30 June 2011: 1.0%). Management fees paid to the Joint Managers are shown in note 12.
No performance incentive fee is payable to the Joint Managers for the period ended 30 June 2012 (six months to 30 June 2011 and year ended 31 December 2011: £nil). Under the terms of the management agreement there is a deficit of some £58.4million to be made up in the net asset value before any further performance incentive fee becomes payable.
| Total term loans as at 30 June 2012 | 301,149 | 82,862 | 384,011 |
|---|---|---|---|
| (3,000) | (5,000) | (8,000) | |
| Reduction in RBS overdraft | - | (5,000) | (5,000) |
| Repayment of and reduction in AIB bank loan | (3,000) | - | (3,000) |
| 304,149 | 87,862 | 392,011 | |
| 1,144 | (1,435) | (291) | |
| Repayment of Aviva mortgage | (291) | - | (291) |
| issue against revolving bank facility | (18,399) | 18,399 | - |
| Temporary offset of proceeds of share | |||
| Term bank repayments | (16,501) | 16,501 | - |
| Term bank drawdowns | 36,335 | (36,335) | - |
| As at 1 January 2012 | 303,005 | 89,297 | 392,302 |
| £000 (unaudited) |
£000 (unaudited) |
£000 (unaudited) |
|
| down | Headroom | facility | |
| Drawn | Total |
Any bank facility arrangement fee amounts unamortised as at the period end are offset against amounts drawn on the facillities as shown in the table below:
| Total term loans per Condensed Group Balance Sheet | 297,566 |
|---|---|
| Total term loans due in greater than one year | 269,956 |
| Less: Unamortised borrowing costs | (3,583) |
| Term loans drawn: due in greater than one year | 273,539 |
| Term loans drawn: due within one year | 27,610 |
| 30 June 2012 £000 (unaudited) |
Net asset values have been calculated as follows:
| 30 June | 30 June | 31 Dec | |
|---|---|---|---|
| 2012 | 2011 | 2011 | |
| £000 | £000 | £000 | |
| (unaudited) | (unaudited) | (audited) | |
| Net assets per Condensed Group Balance Sheet | 185,688 | 188,033 | 168,120 |
| Derivative interest rate swaps liability (net) | 49,266 | 28,641 | 49,481 |
| EPRA net asset value | 234,954 | 216,674 | 217,601 |
| Number | Number | Number | |
| of shares | of shares | of shares | |
| Ordinary Shares: | |||
| Issued share capital | 74,609,070 | 68,175,990 | 68,272,229 |
| Basic net asset value per share | 248.9p | 275.8p | 246.3p |
| EPRA net asset value per share | 314.9p | 317.8p | 318.7p |
The management fee calculated and payable for the period was as follows:
| 30 June | 30 June | 31 Dec | |
|---|---|---|---|
| 2012 | 2011 | 2011 | |
| £000 | £000 | £000 | |
| (unaudited) | (unaudited) | (audited) | |
| Nexus TradeCo Limited | 1,236 | 1,105 | 2,295 |
| J O Hambro Capital Management Limited | 851 | 782 | 1,591 |
On 19 July 2012, PHP announced that it had entered into a conditional contract to acquire a modern, purpose built medical centre in Luton, Bedfordshire for approximately £3.9 million.
On 23 July 2012, PHP announced that it had become the first UK REIT to issue a Retail Bond following the issue of a £75 million, 7 year bond, to Retail Investors with an interest rate of 5.375% paid semi-annually in arrears.
We have been engaged by the Company to review the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2012 which comprises the Condensed Group Statement of Comprehensive Income, Condensed Group Balance Sheet, Condensed Group Cash Flow Statement, Condensed Group Statement of Changes in Equity and the related notes 1 to 13. We have read the other information contained in the halfyearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.
This report is made solely to the Company in accordance with guidance contained in International Standard on Review Engagements 2410 (UK and Ireland) "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" ("ISRE 2410") issued by the Auditing Practices Board. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our work, for this report, or for the conclusions we have formed.
The half-yearly financial report is the responsibility of, and has been approved by, the Directors. The Directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority. As disclosed in note 1, the annual financial statements of the Group are prepared in accordance with International Financial Reporting Standards "IFRS" as adopted by the European Union. The condensed set of financial statements included in this half-yearly financial report has been prepared in accordance with International Accounting
Standard 34, "Interim Financial Reporting", as adopted by the European Union.
Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the half-yearly report based on our review.
We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410 "Review of interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the half-yearly financial report for the six months ended 30 June 2012 is not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.
Ernst & Young LLP London 21 August 2012
The Directors confirm that to the best of their knowledge this condensed set of financial statements has been prepared in accordance with IAS 34 as adopted by the European Union and that the operating and financial review herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8 of the Disclosure and Transparency rules of the United Kingdom's Financial Services Authority namely:
The Directors of Primary Health Properties PLC are listed in the Annual Financial Report for the year ended 31 December 2011. A list of current Directors is shown on page 33. Shareholder information is as disclosed in the Annual Financial Report and is also available on the PHP website www.phpgroup.co.uk.
Graeme Elliot Chairman 21 August 2012
Graeme Elliot (Chairman) Alun Jones (Chairman of Audit Committee and Senior Independent Director) Harry Hyman (Managing Director) Mark Creedy Martin Gilbert (resigned 14 June 2012) William Hemmings (appointed 18 June 2012) James Hambro Dr Ian Rutter OBE
J O Hambro Capital Management Limited, Ground Floor, Ryder Court, 14 Ryder Street, London SW1Y 6QB Tel: 020 7747 5678 Fax: 020 7747 5612
Nexus Tradeco Limited, 2nd Floor, Griffin House, West Street, Woking GU21 6BS Tel: 01483 749020
J O Hambro Capital Management Limited, Ground Floor, Ryder Court, 14 Ryder Street, London SW1Y 6QB Tel: 020 7747 5678
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex BN99 6DA General enquiries: 0871 384 2030* Telephone dealing: 0845 300 0430 Online dealing: www.shareview.co.uk/dealing
Numis Securities Limited, The London Stock Exchange Building, 10 Paternoster Square, London EC4M 7LT
Moor House, 120 London Wall, London, EC2Y 5ET
Nabarro LLP, Lacon House, 84 Theobald's Road, London WC1X 8RW
Tods Murray LLP, Edinburgh Quay, 133 Fountainbridge, Edinburgh EH3 9AG
Auditors Ernst & Young LLP, 1 More London Place, London SE1 2AF
The Royal Bank of Scotland Plc, 280 Bishopsgate, London EC2M 3UR
Allied Irish Banks, p.l.c., St Helen's, 1 Undershaft, London EC3A 8AB
Santander Corporate Banking, 2 Triton Square, Regent's Place, London NW1 3AN
Clydesdale Bank PLC, 5th floor, 33 Gracechurch Street, Surrey Street, London EC3V 0BT
Aviva Commercial Finance Limited, Surrey Street, Norwich NR1 3NJ
Environmental Consultant Collier & Madge, One Great Cumberland Place, London W1H 7AL
Lambert Smith Hampton Group Limited, Interchange Place, Edmund Street, Birmingham B3 2TA
The paper in this report is a FSC certified product, produced with an FSC mixed sources pulp which is fully recyclable, biodegradable & Chlorine free. It is manufactured within a mill which complies with the international environmental ISO 14001 standard.
It has been printed using environmentally friendly vegetable based inks, formulated on the basis of renewable raw materials, vegetable oils are non-hazardous from renewable sources. Over 90% of solvents and developers are recycled for further use and recycling initiatives are in place for all other waste associated with this production. The printers are FSC and ISO 14001 certified with strict procedures in place to safeguard the environment through all their processes and are working on initiatives to reduce their Carbon Footprint.
For further information contact: Harry Hyman, Phil Holland or Tim Walker-Arnott
Telephone: 020 7451 7050
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.